Trump tariffs could soften one of Europe’s most expensive housing markets—if Apple and Pfizer workers are hit with layoffs
Tech and pharma employees in Ireland are at risk from an escalating Trump trade war.
Tech and pharma employees in Ireland are at risk from an escalating Trump trade war.
Shares of Levi Strauss rose Tuesday, a day after the denim giant reported better-than-expected first-quarter profit and gave a relatively upbeat outlook on the Trump administration's new tariffs.
Chip stocks rose Tuesday, extending Monday's gains following a rout sparked by President Donald Trump’s sweeping tariffs and China’s retaliatory measures.
President Trump is told to provide a roadmap to investors how he intends to chart a way out of the tariff crisis he has unleashed before it spirals out of control.
News of the day for April 8, 2025
Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 4.1% year on year to $38.59 billion. Its non-GAAP profit of $0.63 per share was 21% above analysts’ consensus estimates.
Taiwan authorised the activation of its $15 billion stock stabilisation fund on Tuesday to prop up the market after two days of sharp falls in reaction to U.S. President Donald Trump's new import tariffs. Trump last week announced that Taiwan, which runs a large trade surplus with the United States, will get a 32% tariff, sending the markets into a tailspin on Monday after they re-opened following a Thursday and Friday holiday. Taiwan's finance ministry said in a statement that the government-run National Stabilisation Fund, which has some T$500 billion ($15.15 billion) in assets that can bolster Taiwan stocks in times of crisis, had been given the go ahead to intervene in the stock market.
Household products company WD-40 (NASDAQ:WDFC) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 5% year on year to $146.1 million. The company’s full-year revenue guidance of $615 million at the midpoint came in 1.9% below analysts’ estimates. Its GAAP profit of $2.19 per share was 54.2% above analysts’ consensus estimates.
Cannabis company Tilray Brands (NASDAQ:TLRY) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 1.4% year on year to $185.8 million. The company’s full-year revenue guidance of $875 million at the midpoint came in 2% below analysts’ estimates. Its non-GAAP loss of $0 per share was significantly above analysts’ consensus estimates.
After a wild Monday, equity trading appears to have calmed somewhat even as the U.S.-inspired trade war ratchets up. Speculation about a devaluation of China's yuan has moved center stage along with a snapback in U.S. Treasury yields. * China refused to bow to what it called "blackmail" from the United States as a global trade war ignited by President Donald Trump's sweeping tariffs showed little sign of abating on Tuesday.